Trial intelligence / Profile preview

Postoperative palonosetron for prevention of postdischarge nausea and vomiting in ambulatory surgery

2015-003956-32Phase 4Completed

Sponsor
Umeå University
Start
Jan 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in postoperative nausea and vomiting (PONV) comparing Palonosetron with Placebo (2 arms). Primary endpoint: Complete response from discharge to postoperative day 2. Started Jan 2016; status: completed.

02

Drugs

palonosetron
03

Conditions

postoperative nausea and vomiting (PONV)

Beyond the preview

Go deeper on 2015-003956-32.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2015-003956-32.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call